急性髓系白血病中的多药耐药性：潜在的新疗法。 - Suppr

Suppr

超能文献

Multidrug resistance in acute myeloid leukemia: potential new therapeutics.

作者信息

Weisburg Jeffrey H

机构信息

Yeshiva University, New York, New York 10016, USA.

出版信息

J Nucl Med. 2008 Sep;49(9):1405-7. doi: 10.2967/jnumed.107.050153. Epub 2008 Aug 14.

DOI:10.2967/jnumed.107.050153

PMID:18703603

Abstract

摘要

相似文献

Multidrug resistance in acute myeloid leukemia: potential new therapeutics.

J Nucl Med. 2008 Sep;49(9):1405-7. doi: 10.2967/jnumed.107.050153. Epub 2008 Aug 14.

[Molecular targeting therapy by anti-VLA-4 monoclonal antibodies for AML].

Rinsho Ketsueki. 2005 Mar;46(3):198-201.

Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly.

Cancer Treat Rev. 2009 Apr;35(2):97-120. doi: 10.1016/j.ctrv.2008.09.001. Epub 2008 Oct 31.

Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.

Biomed Pharmacother. 2009 Sep;63(8):566-70. doi: 10.1016/j.biopha.2008.10.008. Epub 2008 Dec 6.

Integration of monoclonal antibodies and immunoconjugates into the treatment of acute myeloid leukemia.

Curr Opin Hematol. 2008 Mar;15(2):95-100. doi: 10.1097/MOH.0b013e3282f3de84.

[Treatment of acute myelogenous leukemia and strategies to overcome multidrug resistance].

Rinsho Ketsueki. 2007 Oct;48(10):1300-11.

Investigational agents in myeloid disorders.

Adv Pharmacol. 2004;51:59-97. doi: 10.1016/S1054-3589(04)51003-7.

Introduction: evolution of targeted and multifunctional agents for leukemias and lymphomas.

Semin Hematol. 2008 Jul;45(3 Suppl 2):S1. doi: 10.1053/j.seminhematol.2008.07.002.

[High dosage cytostatic therapy in acute myeloid leukemia].

Lakartidningen. 1982 May 26;79(21):2107-9.

[Molecular diagnosis and therapy in oncology].

Onkologie. 2011;34 Suppl 2:5-9. doi: 10.1159/000324828.

引用本文的文献

ABCB1 polymorphisms correlate with susceptibility to adult acute leukemia and response to high-dose methotrexate.

Tumour Biol. 2015 Sep;36(10):7599-606. doi: 10.1007/s13277-015-3403-5. Epub 2015 Apr 29.

Methyl jasmonate: putative mechanisms of action on cancer cells cycle, metabolism, and apoptosis.

Int J Cell Biol. 2014;2014:572097. doi: 10.1155/2014/572097. Epub 2014 Feb 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Multidrug resistance in acute myeloid leukemia: potential new therapeutics.

作者信息

Weisburg Jeffrey H

机构信息

Yeshiva University, New York, New York 10016, USA.

出版信息

J Nucl Med. 2008 Sep;49(9):1405-7. doi: 10.2967/jnumed.107.050153. Epub 2008 Aug 14.

DOI:10.2967/jnumed.107.050153

PMID:18703603

Abstract

摘要

相似文献

Multidrug resistance in acute myeloid leukemia: potential new therapeutics.

J Nucl Med. 2008 Sep;49(9):1405-7. doi: 10.2967/jnumed.107.050153. Epub 2008 Aug 14.

[Molecular targeting therapy by anti-VLA-4 monoclonal antibodies for AML].

Rinsho Ketsueki. 2005 Mar;46(3):198-201.

Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly.

Cancer Treat Rev. 2009 Apr;35(2):97-120. doi: 10.1016/j.ctrv.2008.09.001. Epub 2008 Oct 31.

Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.

Biomed Pharmacother. 2009 Sep;63(8):566-70. doi: 10.1016/j.biopha.2008.10.008. Epub 2008 Dec 6.

Integration of monoclonal antibodies and immunoconjugates into the treatment of acute myeloid leukemia.

Curr Opin Hematol. 2008 Mar;15(2):95-100. doi: 10.1097/MOH.0b013e3282f3de84.

[Treatment of acute myelogenous leukemia and strategies to overcome multidrug resistance].

Rinsho Ketsueki. 2007 Oct;48(10):1300-11.

Investigational agents in myeloid disorders.

Adv Pharmacol. 2004;51:59-97. doi: 10.1016/S1054-3589(04)51003-7.

Introduction: evolution of targeted and multifunctional agents for leukemias and lymphomas.

Semin Hematol. 2008 Jul;45(3 Suppl 2):S1. doi: 10.1053/j.seminhematol.2008.07.002.

[High dosage cytostatic therapy in acute myeloid leukemia].

Lakartidningen. 1982 May 26;79(21):2107-9.

[Molecular diagnosis and therapy in oncology].

Onkologie. 2011;34 Suppl 2:5-9. doi: 10.1159/000324828.

引用本文的文献

ABCB1 polymorphisms correlate with susceptibility to adult acute leukemia and response to high-dose methotrexate.

Tumour Biol. 2015 Sep;36(10):7599-606. doi: 10.1007/s13277-015-3403-5. Epub 2015 Apr 29.

Methyl jasmonate: putative mechanisms of action on cancer cells cycle, metabolism, and apoptosis.

Int J Cell Biol. 2014;2014:572097. doi: 10.1155/2014/572097. Epub 2014 Feb 6.